These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 31820437)
61. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome. Tolia VN; Murthy K; Bennett MM; Miller ES; Benjamin DK; Smith PB; Clark RH J Perinatol; 2018 Jan; 38(1):75-79. PubMed ID: 29048415 [TBL] [Abstract][Full Text] [Related]
62. Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale. Jones HE; Seashore C; Johnson E; Horton E; O'Grady KE; Andringa K; Grossman MR; Whalen B; Holmes AV Am J Addict; 2016 Aug; 25(5):370-3. PubMed ID: 27287965 [TBL] [Abstract][Full Text] [Related]
63. The genetics and epigenetics of Neonatal Abstinence Syndrome. Wachman EM; Farrer LA Semin Fetal Neonatal Med; 2019 Apr; 24(2):105-110. PubMed ID: 30709700 [TBL] [Abstract][Full Text] [Related]
64. Could prenatal food insecurity influence neonatal abstinence syndrome severity? Rose-Jacobs R; Trevino-Talbot M; Lloyd-Travaglini C; Cabral HJ; Vibbert M; Saia K; Wachman EM Addiction; 2019 Feb; 114(2):337-343. PubMed ID: 30422365 [TBL] [Abstract][Full Text] [Related]
65. [Methadone treatment and its dangers]. Reingardiene D; Jodziūniene L; Lazauskas R Medicina (Kaunas); 2009; 45(5):419-25. PubMed ID: 19535889 [TBL] [Abstract][Full Text] [Related]
66. Treating Neonatal Abstinence Syndrome in a Rural Hospital: Lessons Learned. Gadomski A; Riley M; Ramiza K; Onofrey L; Zinkievich R; Krupa N; Scribani M Acad Pediatr; 2018; 18(4):425-429. PubMed ID: 29428413 [TBL] [Abstract][Full Text] [Related]
67. Distribution of R- and S-methadone into human milk during multiple, medium to high oral dosing. Begg EJ; Malpas TJ; Hackett LP; Ilett KF Br J Clin Pharmacol; 2001 Dec; 52(6):681-5. PubMed ID: 11736879 [TBL] [Abstract][Full Text] [Related]
68. Treatment of neonatal abstinence syndrome. Johnson K; Gerada C; Greenough A Arch Dis Child Fetal Neonatal Ed; 2003 Jan; 88(1):F2-5. PubMed ID: 12496218 [TBL] [Abstract][Full Text] [Related]
69. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. Dryden C; Young D; Hepburn M; Mactier H BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239 [TBL] [Abstract][Full Text] [Related]
70. The Role of Preterm Birth in the Association Between Opioid Maintenance Therapy and Neonatal Abstinence Syndrome. Lemon LS; Naimi A; Caritis SN; Platt RW; Venkataramanan R; Bodnar LM Paediatr Perinat Epidemiol; 2018 Mar; 32(2):213-222. PubMed ID: 29372750 [TBL] [Abstract][Full Text] [Related]
72. Reply to 'Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial'. Brown MS J Perinatol; 2015 Oct; 35(10):892. PubMed ID: 26412406 [No Abstract] [Full Text] [Related]
73. Pharmacokinetics of the injectable formulation of methadone hydrochloride administered orally in horses. Linardi RL; Stokes AM; Barker SA; Short C; Hosgood G; Natalini CC J Vet Pharmacol Ther; 2009 Oct; 32(5):492-7. PubMed ID: 19754917 [TBL] [Abstract][Full Text] [Related]
74. Buprenorphine: a new player in neonatal withdrawal syndrome. Nanda S; Brant R; Regier M; Yossuck P W V Med J; 2015; 111(1):16-21. PubMed ID: 25665273 [TBL] [Abstract][Full Text] [Related]
76. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway. Nechanská B; Mravčík V; Skurtveit S; Lund IO; Gabrhelík R; Engeland A; Handal M Addiction; 2018 Jul; 113(7):1286-1294. PubMed ID: 29443414 [TBL] [Abstract][Full Text] [Related]
77. Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates. Jansson LM; Dipietro JA; Elko A; Velez M J Matern Fetal Neonatal Med; 2007 Sep; 20(9):677-85. PubMed ID: 17701668 [TBL] [Abstract][Full Text] [Related]
78. Increased Severity of Neonatal Abstinence Syndrome Associated With Concomitant Antenatal Opioid and Benzodiazepine Exposure. Sanlorenzo LA; Cooper WO; Dudley JA; Stratton S; Maalouf FI; Patrick SW Hosp Pediatr; 2019 Aug; 9(8):569-575. PubMed ID: 31262946 [TBL] [Abstract][Full Text] [Related]
79. Using population data to examine the prevalence and correlates of neonatal abstinence syndrome. Burns L; Mattick RP Drug Alcohol Rev; 2007 Sep; 26(5):487-92. PubMed ID: 17701511 [TBL] [Abstract][Full Text] [Related]
80. Pharmacologic management of neonatal abstinence syndrome in a community hospital. Napolitano A; Theophilopoulos D; Seng SK; Calhoun DA Clin Obstet Gynecol; 2013 Mar; 56(1):193-201. PubMed ID: 23314713 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]